MyFinsight
Home
Blog
About
Back
Income Statement
Crinetics Pharmaceuticals, Inc. (CRNX)
Crinetics Pharmaceuticals, Inc. (CRNX)
source: myfinsight.com
Comprehensive loss
-$122,609K
(-5.68%↓ Y/Y)
Interest income
$12,027K
(-10.61%↓ Y/Y)
Net loss
-$120,855K
(-4.51%↓ Y/Y)
Total other
comprehensive income (gain)
-$1,754K
(-360.37%↓ Y/Y)
Total other income,
net
$11,604K
(-13.88%↓ Y/Y)
Unrealized gain (loss) on
foreign currency
$145K
(526.47%↑ Y/Y)
Product
$24,038K
License And Service
$1,080K
Other (expense)
income, net
-$423K
Loss from operations
-$132,459K
(-2.59%↓ Y/Y)
Unrealized loss (gain) on
investment securities
-$1,899K
(-447.26%↓ Y/Y)
Total revenue
$25,118K
(2336.28%↑ Y/Y)
Total operating
expenses
$157,577K
(21.08%↑ Y/Y)
Research and development
$99,850K
(24.34%↑ Y/Y)
Selling, general and
administrative
$57,573K
(15.51%↑ Y/Y)
Cost of product
revenue
$154K
Back